Levoketoconazole and Ibrexafungerp: Interaction Details
- Ibrexafungerp
- Brexafemme
- Levoketoconazole
- Recorlev
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Levoketoconazole and Ibrexafungerp interaction:
Ibrexafungerp
- Brexafemme
We don't have a drug information page for Ibrexafungerp yet. Have a question about Ibrexafungerp? Ask a pharmacist, free →
Levoketoconazole
- Recorlev
What Happens When You Take Levoketoconazole With Ibrexafungerp
What can happen when they are taken together (rated Contraindicated)
Increased exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Levoketoconazole must not be given together with sensitive CYP3A4 substrates, as this combination is . Because levoketoconazole inhibits CYP3A4, using it alongside a sensitive CYP3A4 substrate can raise the substrate's exposure, which in turn may heighten the risk of adverse reactions associated with that substrate. A drug interaction study found that giving levoketoconazole 400 mg once daily with felodipine, a sensitive CYP3A4 substrate, raised felodipine by 1007% and by 937%.1
The Levoketoconazole and Ibrexafungerp Interaction, Explained
These two medicines should not be taken together. Levoketoconazole (Recorlev) blocks , a liver enzyme that helps clear many drugs. Ibrexafungerp (Brexafemme), a yeast infection medicine, is broken down partly by this enzyme, so levels of it in your body could rise. Higher levels may raise the chance of side effects such as nausea, vomiting, diarrhea, and stomach pain. In one study, levoketoconazole raised levels of a different CYP3A4-processed drug about tenfold.
Please don't start or stop either medicine on your own. Tell your pharmacist or doctor about both, and they can choose a safer plan for you.
Mechanism: Levoketoconazole is a strong . Ibrexafungerp is a CYP3A4 , so is expected to raise its exposure (PK interaction, increased drug effect and adverse reactions).
- Magnitude: With levoketoconazole 400 mg daily, felodipine (a sensitive CYP3A4 substrate) rose 1007% and 937%. This is a class-based extrapolation for ibrexafungerp, not a direct study.
- Onset: Unspecified.
- Evidence: Probable.
- Management: Coadministration with sensitive CYP3A4 substrates is per labeling. Consider an alternative antifungal or alternative therapy, and review the full regimen with the prescriber.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Levoketoconazole and Ibrexafungerp Interact
The likely mechanism
of -substrate by levoketoconazole
How to Manage the Levoketoconazole and Ibrexafungerp Interaction
Because this combination is , your care team will usually look for a different option rather than adjusting doses.
- Keep taking your medicines as prescribed until you speak with your pharmacist or prescriber. Do not stop either one on your own.
- Tell them about every medicine you take, including both of these, so they can review the plan.
- Your team may choose an alternative treatment and may monitor you more closely.
- Contact them promptly if you notice troublesome stomach upset, vomiting, or diarrhea.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Levoketoconazole or Ibrexafungerp need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: RECORLEV oral tablets, levoketoconazole oral tablets
In a drug interaction study (N=14), felodipine, a sensitive , was given together with levoketoconazole 400 mg once daily. Compared with felodipine given alone, this raised felodipine by 1007% and by 937%.1
Levoketoconazole and Ibrexafungerp: Common Questions
How serious is the Levoketoconazole and Ibrexafungerp interaction?
It is rated . These should generally not be used together.
How is the Levoketoconazole and Ibrexafungerp interaction managed?
Because this combination is , your care team will usually look for a different option rather than adjusting doses. Keep taking your medicines as prescribed until you speak with your pharmacist or prescriber. Do not stop either one on your own. Tell them about every medicine you take, including both of these, so they can review the plan. Your team may choose an alternative treatment… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Levoketoconazole and Ibrexafungerp Interaction
Ask in your own words about taking Levoketoconazole and Ibrexafungerp together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: RECORLEV(R) oral tablets, levoketoconazole oral tablets. Xeris Pharmaceuticals Inc (per FDA), Chicago, IL, 2023. DailyMed
Other Serious Interactions of Levoketoconazole and Ibrexafungerp
Also serious with Ibrexafungerp
Also serious with Levoketoconazole
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together. This interaction.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.